Cargando…

Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience

BACKGROUND: Among hospitalized patients, indications for the measurement of magnesium levels and treatment of hypomagnesemia with intravenous magnesium are not well defined. Recently, there have been reports of worldwide shortages of intravenous magnesium sulphate. OBJECTIVE: To examine secular tren...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiberd, Bryce A., Tennankore, Karthik K., Daley, Christopher J. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477498/
https://www.ncbi.nlm.nih.gov/pubmed/26106483
http://dx.doi.org/10.1186/s40697-015-0056-7
_version_ 1782377773450395648
author Kiberd, Bryce A.
Tennankore, Karthik K.
Daley, Christopher J. A.
author_facet Kiberd, Bryce A.
Tennankore, Karthik K.
Daley, Christopher J. A.
author_sort Kiberd, Bryce A.
collection PubMed
description BACKGROUND: Among hospitalized patients, indications for the measurement of magnesium levels and treatment of hypomagnesemia with intravenous magnesium are not well defined. Recently, there have been reports of worldwide shortages of intravenous magnesium sulphate. OBJECTIVE: To examine secular trends in the administration of intravenous magnesium on hospital wards at a tertiary care institution. The secondary objective is to identify factors associated with magnesium use among admitted patients. METHODS: Retrospective cross-section review of hospitalized patients at a single Canadian tertiary care center. Utilization of non-parental nutrition intravenous magnesium from 2003 to 2013 stratified by hospital ward was examined. In addition, patient level data from select wards (including medical and surgical services) was examined at early and more recent time period (4/2006 versus 4/2013). RESULTS: Among the 248,329 hospitalized patients, intravenous magnesium use increased by 2.86 fold from 2003 to 2013. Not all wards had an increase whereas some had nearly a 10 fold increase in use. In the sample (n = 769), (adjusting for admission magnesium level, presence of an indication for intravenous magnesium, ward location, comorbidity and demographics) intravenous magnesium administration was higher (25.8 % versus 5.5 %) in 2013 versus 2006 (OR 13.91 (95 % CI, 6.21-31.17, p < 0.001). Despite this increase in intravenous magnesium administration, <3 % of patients were admitted on oral magnesium in 2006 and 2013. For patients receiving intravenous magnesium only a minority were discharged on oral therapy despite low levels. CONCLUSIONS: This center has witnessed a considerable increase in the use of in-hospital intravenous magnesium over the last 6 years that cannot be explained for by medical indications. The risks and benefits of this therapy deserve further study. If this change in practice is representative of other North American hospitals, it may be responsible for recent drug shortages.
format Online
Article
Text
id pubmed-4477498
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44774982015-06-24 Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience Kiberd, Bryce A. Tennankore, Karthik K. Daley, Christopher J. A. Can J Kidney Health Dis Original Research Article BACKGROUND: Among hospitalized patients, indications for the measurement of magnesium levels and treatment of hypomagnesemia with intravenous magnesium are not well defined. Recently, there have been reports of worldwide shortages of intravenous magnesium sulphate. OBJECTIVE: To examine secular trends in the administration of intravenous magnesium on hospital wards at a tertiary care institution. The secondary objective is to identify factors associated with magnesium use among admitted patients. METHODS: Retrospective cross-section review of hospitalized patients at a single Canadian tertiary care center. Utilization of non-parental nutrition intravenous magnesium from 2003 to 2013 stratified by hospital ward was examined. In addition, patient level data from select wards (including medical and surgical services) was examined at early and more recent time period (4/2006 versus 4/2013). RESULTS: Among the 248,329 hospitalized patients, intravenous magnesium use increased by 2.86 fold from 2003 to 2013. Not all wards had an increase whereas some had nearly a 10 fold increase in use. In the sample (n = 769), (adjusting for admission magnesium level, presence of an indication for intravenous magnesium, ward location, comorbidity and demographics) intravenous magnesium administration was higher (25.8 % versus 5.5 %) in 2013 versus 2006 (OR 13.91 (95 % CI, 6.21-31.17, p < 0.001). Despite this increase in intravenous magnesium administration, <3 % of patients were admitted on oral magnesium in 2006 and 2013. For patients receiving intravenous magnesium only a minority were discharged on oral therapy despite low levels. CONCLUSIONS: This center has witnessed a considerable increase in the use of in-hospital intravenous magnesium over the last 6 years that cannot be explained for by medical indications. The risks and benefits of this therapy deserve further study. If this change in practice is representative of other North American hospitals, it may be responsible for recent drug shortages. BioMed Central 2015-06-13 /pmc/articles/PMC4477498/ /pubmed/26106483 http://dx.doi.org/10.1186/s40697-015-0056-7 Text en © Kiberd et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Research Article
Kiberd, Bryce A.
Tennankore, Karthik K.
Daley, Christopher J. A.
Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience
title Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience
title_full Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience
title_fullStr Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience
title_full_unstemmed Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience
title_short Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience
title_sort increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477498/
https://www.ncbi.nlm.nih.gov/pubmed/26106483
http://dx.doi.org/10.1186/s40697-015-0056-7
work_keys_str_mv AT kiberdbrycea increasesinintravenousmagnesiumuseamonghospitalizedpatientsaninstitutioncrosssectionalexperience
AT tennankorekarthikk increasesinintravenousmagnesiumuseamonghospitalizedpatientsaninstitutioncrosssectionalexperience
AT daleychristopherja increasesinintravenousmagnesiumuseamonghospitalizedpatientsaninstitutioncrosssectionalexperience